BibTex RIS Cite

HİPERTANSİYONLU HASTALARDA ERİTROSİT İÇİ ANTİOKSİDAN ENZİM VE SERUM MALONDİALDEHİT DÜZEYLERİNİN ARAŞTIRILMASI

Year 2005, Volume: 14 Issue: 2, 76 - 82, 01.06.2005

Abstract

Serbest oksijen radikalleri veya reaktif oksijen türleri (ROS), hipertansiyonun patogenezinde rolü olduğuna inanılan ve endojen olarak vücutta sentez edilen metabolik yan ürünlerdir. Bu ürünler sentez edildikleri yerde hemen detoksifiye edilmezlerse zararlı etki oluşturabilirler. Son çalışmalarda hipertansiyonun, kardiyovasküler hastalıkların gelişiminde rol oynayan oksijen kaynaklı serbest radikallerin oluşumuna yol açtığı belirtilmektedir. Bu çalışmada 25’i erkek, 20’si kadın olmak toplam 45 esansiyel hipertansiyonlu hasta incelendi. Kontrol grubu tamamen sağlıklı 23’ü kadın, 22’si erkek toplam 45 kişiden oluşturuldu. Eritrosit örneklerinde süperoksit dismutaz (SOD), glutatyon peroksidaz (GSH-PX), katalaz (CAT) ve serumda malondialdehit (MDA) seviyeleri ölçüldü ve istatistiksel olarak karşılaştırıldı. Hipertansif hastalar kontrol grubu ile karşılaştırıldığında, eritrosit içi SOD, GSH-PX ve CAT değerlerinin hipertansif hastalarda anlamlı biçimde düşük olduğu (p<0.05) gösterildi. Serum MDA değeri ise hipertansiyon grubunda anlamlı biçimde daha yüksekti (p<0.001). Bu verilerle hipertansif hastalarda serbest radikal hasarına karşı koruyucu bir özellik sergileyen antioksidan enzim sistemlerinin normalden daha düşük olduğu, serbest oksijen radikallerinin artığı, bu nedenlerle bu hastaların ciddi bir oksidatif stresle karşı karşıya oldukları ve dolaylı olarak da, bu sistemleri düzeltici girişimlerin hipertansiyonun önlenmesinde etkili olabileceği sonuçlarına varıldı

References

  • Marques-Vidal P, Tuomilehoto J. Hypertension awareness, treatment and control in the community: Is the ‘’rule of halves’’ sill valid? Hum Hypertens 1997, 11:213-220.
  • Rudd P, Hagar W. Hypertension: mechanisms, diagnosis and therapy. In: Topol EJ. Textbook of Cardiovascular Medicine. Philadelphia Lippincott-Raven 1998, pp 109-144. 3. Singh JP, Larson MG, Manolio TA, et al. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension: the framingham heart study. Circulation 1999, 99:1831-1836.
  • Sinnuber RO, Yut C, Chang YT. Chareterization of the red pigment formed in the thiobarbituric acid determination of oxidative rancidity. Food Res 1958, 23:626- 632.
  • Sakawa T, Matsushıta S. Coloring condition of thiobarbituric acid test of detecting lipids hydroperoxides. Lipids 1980, 15:137-144.
  • Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988, 34:497-450.
  • Aebi H Catalase. In Bergmeyer, U., ed. Methods of Enzymatic Analysis. Academic Press W, New York and London.1974, pp 673-677.
  • Paglia DE, Studies on the quantitative and qualitative characterisationof erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70: 158-169.
  • Valentine Sümbüloğlu K, Sümbüloğlu V. Biyoistatistik. Hacettepe Üniversitesi Tıp Fak. Biyoistatistik Bilim Dalı, 4 Basım Öz- demir Yayıncılık LTD Şirketi, Ankara 1993, ss 70- 99.
  • Gianetti J, Pedrinelli R, Petrucci R, et al. Inverse association between carotid intima- media thickness and the antioxidant lycopene in atherosclerosis. AM Heart J 2002, 143: 467-474.
  • Yakobson MG, Antonov AR, Golovatyuk AV, et al. Iron content and parameters of blood antioxidant activity in rats with hereditary arterial hypertension during experimental myocardial ınfarction. Bull Exp Biol Med 2001, 1041-1049.
  • Johnson P. Antioxidant enzyme expression in health and disease: effects of exercise and hypertension. Comp Biochem Physiol C Toxicol Pharmacol 2002, 133:493-505.
  • Behathena RK, Anklesaria BS, Ganatra AM, Pinto R. The influence of transdermal oestradiol replacement and medroxyprogesterone acetate on serum lipids and lipoproteins. Br J Clin Pharmacol 1998, 45: 170-172.
  • Vaziri ND, Lin CY, Farmand F, Sindhu RK. Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead- induced hypertension. Kidney Int 2003, 63:186-94.
  • Suematsu M, Suzuki H, Delano FA, Schmid- Schonbein GW. The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation 2002, 9: 259-76.
  • Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003, 41:1096-1101.
  • Kim CH, Vaziri ND. Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes. Kidney Int 2005, 67: 1462-1470.

The Investigation of Serum Malondialdehyde Levels and Erythrocyte Antioxidant Enzymes in Hypertension Patients

Year 2005, Volume: 14 Issue: 2, 76 - 82, 01.06.2005

Abstract

Free oxygen radicals, produced endogenically through body metabolism play a role in the pathogenesis of hypertension. They have detrimental effects unless they are detoxified. Recent studies have demonstrated their role in cardiovascular diseases. This study included 45 essential hypertension patients (25 males, 20 females) and 45 healthy controls (22 males, 23 females). The levels of serum malondialdehyde (MDA) and erythrocyte’s superoxide dismutase (SOD), glutathione peroxidase (GSH-PX) and catalase (CAT) enzymes were all determined and statistically assessed. Erythrocytes levels of SOD, GSH-PX and CAT were statistically decreased (p<0.05) whereas serum level of MDA was statistically increased (p<0.001) The data demonstrated that the levels of antioxidant enzymes systems in hypertensive patients which have protective properties against the damaging effects of free radicals were reduced and therefore such patients are faced with a serious oxidative stress. It was concluded that interventions intended to regulate there antioxidant enzymes systems might be effective in preventing hypertension

References

  • Marques-Vidal P, Tuomilehoto J. Hypertension awareness, treatment and control in the community: Is the ‘’rule of halves’’ sill valid? Hum Hypertens 1997, 11:213-220.
  • Rudd P, Hagar W. Hypertension: mechanisms, diagnosis and therapy. In: Topol EJ. Textbook of Cardiovascular Medicine. Philadelphia Lippincott-Raven 1998, pp 109-144. 3. Singh JP, Larson MG, Manolio TA, et al. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension: the framingham heart study. Circulation 1999, 99:1831-1836.
  • Sinnuber RO, Yut C, Chang YT. Chareterization of the red pigment formed in the thiobarbituric acid determination of oxidative rancidity. Food Res 1958, 23:626- 632.
  • Sakawa T, Matsushıta S. Coloring condition of thiobarbituric acid test of detecting lipids hydroperoxides. Lipids 1980, 15:137-144.
  • Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988, 34:497-450.
  • Aebi H Catalase. In Bergmeyer, U., ed. Methods of Enzymatic Analysis. Academic Press W, New York and London.1974, pp 673-677.
  • Paglia DE, Studies on the quantitative and qualitative characterisationof erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70: 158-169.
  • Valentine Sümbüloğlu K, Sümbüloğlu V. Biyoistatistik. Hacettepe Üniversitesi Tıp Fak. Biyoistatistik Bilim Dalı, 4 Basım Öz- demir Yayıncılık LTD Şirketi, Ankara 1993, ss 70- 99.
  • Gianetti J, Pedrinelli R, Petrucci R, et al. Inverse association between carotid intima- media thickness and the antioxidant lycopene in atherosclerosis. AM Heart J 2002, 143: 467-474.
  • Yakobson MG, Antonov AR, Golovatyuk AV, et al. Iron content and parameters of blood antioxidant activity in rats with hereditary arterial hypertension during experimental myocardial ınfarction. Bull Exp Biol Med 2001, 1041-1049.
  • Johnson P. Antioxidant enzyme expression in health and disease: effects of exercise and hypertension. Comp Biochem Physiol C Toxicol Pharmacol 2002, 133:493-505.
  • Behathena RK, Anklesaria BS, Ganatra AM, Pinto R. The influence of transdermal oestradiol replacement and medroxyprogesterone acetate on serum lipids and lipoproteins. Br J Clin Pharmacol 1998, 45: 170-172.
  • Vaziri ND, Lin CY, Farmand F, Sindhu RK. Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead- induced hypertension. Kidney Int 2003, 63:186-94.
  • Suematsu M, Suzuki H, Delano FA, Schmid- Schonbein GW. The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation 2002, 9: 259-76.
  • Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003, 41:1096-1101.
  • Kim CH, Vaziri ND. Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes. Kidney Int 2005, 67: 1462-1470.
There are 16 citations in total.

Details

Other ID JA38AB32RV
Journal Section Research Article
Authors

Nihayet M. Bayraktar This is me

Süleyman Kılıç This is me

İlknur Özdemir This is me

Songül Aydemir This is me

Ramazan Ulu This is me

Publication Date June 1, 2005
Submission Date June 1, 2005
Published in Issue Year 2005 Volume: 14 Issue: 2

Cite

APA Bayraktar, N. M., Kılıç, S., Özdemir, İ., Aydemir, S., et al. (2005). HİPERTANSİYONLU HASTALARDA ERİTROSİT İÇİ ANTİOKSİDAN ENZİM VE SERUM MALONDİALDEHİT DÜZEYLERİNİN ARAŞTIRILMASI. Sağlık Bilimleri Dergisi, 14(2), 76-82.
AMA Bayraktar NM, Kılıç S, Özdemir İ, Aydemir S, Ulu R. HİPERTANSİYONLU HASTALARDA ERİTROSİT İÇİ ANTİOKSİDAN ENZİM VE SERUM MALONDİALDEHİT DÜZEYLERİNİN ARAŞTIRILMASI. JHS. June 2005;14(2):76-82.
Chicago Bayraktar, Nihayet M., Süleyman Kılıç, İlknur Özdemir, Songül Aydemir, and Ramazan Ulu. “HİPERTANSİYONLU HASTALARDA ERİTROSİT İÇİ ANTİOKSİDAN ENZİM VE SERUM MALONDİALDEHİT DÜZEYLERİNİN ARAŞTIRILMASI”. Sağlık Bilimleri Dergisi 14, no. 2 (June 2005): 76-82.
EndNote Bayraktar NM, Kılıç S, Özdemir İ, Aydemir S, Ulu R (June 1, 2005) HİPERTANSİYONLU HASTALARDA ERİTROSİT İÇİ ANTİOKSİDAN ENZİM VE SERUM MALONDİALDEHİT DÜZEYLERİNİN ARAŞTIRILMASI. Sağlık Bilimleri Dergisi 14 2 76–82.
IEEE N. M. Bayraktar, S. Kılıç, İ. Özdemir, S. Aydemir, and R. Ulu, “HİPERTANSİYONLU HASTALARDA ERİTROSİT İÇİ ANTİOKSİDAN ENZİM VE SERUM MALONDİALDEHİT DÜZEYLERİNİN ARAŞTIRILMASI”, JHS, vol. 14, no. 2, pp. 76–82, 2005.
ISNAD Bayraktar, Nihayet M. et al. “HİPERTANSİYONLU HASTALARDA ERİTROSİT İÇİ ANTİOKSİDAN ENZİM VE SERUM MALONDİALDEHİT DÜZEYLERİNİN ARAŞTIRILMASI”. Sağlık Bilimleri Dergisi 14/2 (June 2005), 76-82.
JAMA Bayraktar NM, Kılıç S, Özdemir İ, Aydemir S, Ulu R. HİPERTANSİYONLU HASTALARDA ERİTROSİT İÇİ ANTİOKSİDAN ENZİM VE SERUM MALONDİALDEHİT DÜZEYLERİNİN ARAŞTIRILMASI. JHS. 2005;14:76–82.
MLA Bayraktar, Nihayet M. et al. “HİPERTANSİYONLU HASTALARDA ERİTROSİT İÇİ ANTİOKSİDAN ENZİM VE SERUM MALONDİALDEHİT DÜZEYLERİNİN ARAŞTIRILMASI”. Sağlık Bilimleri Dergisi, vol. 14, no. 2, 2005, pp. 76-82.
Vancouver Bayraktar NM, Kılıç S, Özdemir İ, Aydemir S, Ulu R. HİPERTANSİYONLU HASTALARDA ERİTROSİT İÇİ ANTİOKSİDAN ENZİM VE SERUM MALONDİALDEHİT DÜZEYLERİNİN ARAŞTIRILMASI. JHS. 2005;14(2):76-82.